Loading clinical trials...
Loading clinical trials...
The aim of this single-arm pre-post study is to examine the effectiveness of gaming-based dementia educational programs for enhancing healthcare students' attitudes toward people living with dementia (PLWD). The main questions we intend to answer follow: * What are the attitudes toward PLWD, intentions to help PLWD, knowledge of dementia, and stigma of PLWD before and after participation in the gaming-based dementia education program? * What is the effect of gaming-based dementia education programs on enhancing attitudes toward PLWD? Participants will volunteer for the class education program, which will last about 90 minutes. Participants can attend the class only once. This education program based on gaming tools will be structured with a lecture on dementia, N-impro (gaming tools), and bad/good short dramas. The gaming education program will be included in dementia-related courses.
Participants in this study will be healthcare students at an Indonesian university (i.e., nursing students, public health students, etc.) enrolled in the semesters and courses designated for implementation of this educational program. For example, nursing students at Airlangga University will be among students in their fifth semester. Prospective participants will be given new ID numbers to ensure that their student ID numbers are undetected. The protocol for this study was reviewed and approved by an ethical committee of the Faculty of Nursing at Airlangga University. Regarding recruitment, all candidate participants will be identified from the university's e-learning portal data. Students registered in the courses selected for implementation of this education program will have their data recorded at the beginning of the odd semester for the 2023/2024 academic year. Potentially eligible candidates will receive comprehensive study information and an invitation to participate. The courses coordinator and Principal Investigator (PI) will explain the Semester Learning Plan and curriculum for the selected courses at the beginning of the semester. An overview of the research session's implementation will be presented, while detailed research procedures will be explained shortly before research is undertaken. An announcement regarding implementation of the research will be made approximately one week in advance, and recruitment will be carried out through Google Forms. Candidate participants will receive new IDs for this study and information about the schedule and location of the educational program through a class announcement three days prior. On the intervention date, candidate participants will be present at the designated location and sign an attendance sheet using their new IDs. The PI will explain all stages of the study and reiterate regarding participants' freedom to withdraw at any time. The recruitment of study participants will not involve coercion. Students who choose not to participate in this study will still receive regular dementia-related materials through the university's e-learning portal, but they will not receive the game-based education program. Students who agree to participate in the study will provide informed consent. Further, participants in the educational program will complete a questionnaire before and after its implementation.
Age
All ages
Sex
ALL
Healthy Volunteers
Yes
Universitas Airlangga
Surabaya, East Java, Indonesia
Start Date
November 22, 2023
Primary Completion Date
May 30, 2024
Completion Date
July 30, 2024
Last Updated
November 19, 2025
400
ACTUAL participants
Health Education
OTHER
Lead Sponsor
Universitas Airlangga
Collaborators
NCT04246437
NCT05508789
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions